IRIS Accounts Production v25.1.0.734 07394815 Board of Directors 1.11.23 31.10.24 31.10.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh073948152023-10-31073948152024-10-31073948152023-11-012024-10-31073948152022-10-31073948152022-11-012023-10-31073948152023-10-3107394815ns15:EnglandWales2023-11-012024-10-3107394815ns14:PoundSterling2023-11-012024-10-3107394815ns10:Director12023-11-012024-10-3107394815ns10:PrivateLimitedCompanyLtd2023-11-012024-10-3107394815ns10:SmallEntities2023-11-012024-10-3107394815ns10:AuditExempt-NoAccountantsReport2023-11-012024-10-3107394815ns10:SmallCompaniesRegimeForDirectorsReport2023-11-012024-10-3107394815ns10:SmallCompaniesRegimeForAccounts2023-11-012024-10-3107394815ns10:FullAccounts2023-11-012024-10-3107394815ns10:OrdinaryShareClass12023-11-012024-10-3107394815ns10:OrdinaryShareClass22023-11-012024-10-3107394815ns5:CurrentFinancialInstruments2024-10-3107394815ns5:CurrentFinancialInstruments2023-10-3107394815ns5:ShareCapital2024-10-3107394815ns5:ShareCapital2023-10-3107394815ns5:RetainedEarningsAccumulatedLosses2024-10-3107394815ns5:RetainedEarningsAccumulatedLosses2023-10-3107394815ns10:RegisteredOffice2023-11-012024-10-3107394815ns5:MotorVehicles2023-10-3107394815ns5:ComputerEquipment2023-10-3107394815ns5:MotorVehicles2023-11-012024-10-3107394815ns5:ComputerEquipment2023-11-012024-10-3107394815ns5:MotorVehicles2024-10-3107394815ns5:ComputerEquipment2024-10-3107394815ns5:MotorVehicles2023-10-3107394815ns5:ComputerEquipment2023-10-3107394815ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-3107394815ns5:WithinOneYearns5:CurrentFinancialInstruments2023-10-3107394815ns10:OrdinaryShareClass12024-10-3107394815ns10:OrdinaryShareClass22024-10-31073948151ns10:Director12023-10-31073948151ns10:Director12022-10-31073948151ns10:Director12023-11-012024-10-31073948151ns10:Director12022-11-012023-10-31073948151ns10:Director12024-10-31073948151ns10:Director12023-10-31
REGISTERED NUMBER: 07394815 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st October 2024

for

Steven Gill Anaesthetic Services Ltd

Steven Gill Anaesthetic Services Ltd (Registered number: 07394815)






Contents of the Financial Statements
for the Year Ended 31st October 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


Steven Gill Anaesthetic Services Ltd (Registered number: 07394815)

Balance Sheet
31st October 2024

31.10.24 31.10.23
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 64,699 -

CURRENT ASSETS
Debtors 5 147,079 125,648
Cash at bank 175,571 193,268
322,650 318,916
CREDITORS
Amounts falling due within one year 6 14,006 32,404
NET CURRENT ASSETS 308,644 286,512
TOTAL ASSETS LESS CURRENT
LIABILITIES

373,343

286,512

PROVISIONS FOR LIABILITIES 12,293 -
NET ASSETS 361,050 286,512

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 360,950 286,412
SHAREHOLDERS' FUNDS 361,050 286,512

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st October 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8th May 2025 and were signed on its behalf by:





Dr S P Gill - Director


Steven Gill Anaesthetic Services Ltd (Registered number: 07394815)

Notes to the Financial Statements
for the Year Ended 31st October 2024

1. COMPANY INFORMATION

Steven Gill Anaesthetic Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 07394815

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis:

Computer equipment - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Steven Gill Anaesthetic Services Ltd (Registered number: 07394815)

Notes to the Financial Statements - continued
for the Year Ended 31st October 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Research and development expenditure
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1st November 2023 - 958 958
Additions 79,670 1,284 80,954
At 31st October 2024 79,670 2,242 81,912
DEPRECIATION
At 1st November 2023 - 958 958
Charge for year 15,934 321 16,255
At 31st October 2024 15,934 1,279 17,213
NET BOOK VALUE
At 31st October 2024 63,736 963 64,699
At 31st October 2023 - - -

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.24 31.10.23
£    £   
Trade debtors 6,146 4,535
Other debtors 140,933 121,113
147,079 125,648

Included in debtors is a loan of £140,933.23 (2023: £121,113) to a company, Safe IV Ltd, of which the director is sole director and shareholder. All transactions were at arms length.

The loan relates to costs incurred in respect of patent applications and development costs of a medical device designed by the director and previously held as prepayments, until they could be capitalized once the patent was granted.

The patent attorneys engaged in respect of the patent applications, advised the director that it would be beneficial if these costs were kept separately from his trading income and a new company was incorporated for this purpose.

The loan will not be repaid until Safe IV Ltd is earning income form either the device or the sale of patents. No interest is currently charged on this loan.

Steven Gill Anaesthetic Services Ltd (Registered number: 07394815)

Notes to the Financial Statements - continued
for the Year Ended 31st October 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.24 31.10.23
£    £   
Corporation tax payable 6,149 29,277
Social security and other taxes 617 -
Directors' current accounts 5,273 1,082
Accrued expenses 1,967 2,045
14,006 32,404

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.10.24 31.10.23
value: £    £   
60 Ordinary A £1 60 60
40 Ordinary B £1 40 40
100 100

The Ordinary A shares confer on the holder the right to vote upon any resolution proposed at any general meeting of the company.

The Ordinary B shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The Ordinary A and Ordinary B shares rank pari passu in respect of dividend and capital distribution rights.

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st October 2024 and 31st October 2023:

31.10.24 31.10.23
£    £   
Dr S P Gill
Balance outstanding at start of year (5,082 ) (4,130 )
Amounts advanced 100,000 11,000
Amounts repaid (100,191 ) (11,952 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (5,273 ) (5,082 )

The loan is repayable on demand and no interest was charged during the year.

9. CONTROL

The ultimate controlling party is Dr S P Gill by virtue of holding 100% of the voting share capital.